Relationship between serum PD-L1 levels and prognosis of gastric cancer patients by CHEN Changqiang, YAN Xiaowei, HU Jiele, BAO Xiting, XIANG Ming, JIANG Songyao

Subjects: “…|gastric cancer|programmed death-ligand 1（pd-l1）|serum…”
Get full text

Differential Cytokine-Induced Responses of Polarized Microglia by Priyanka Chauhan, Wen S. Sheng, Shuxian Hu, Sujata Prasad, James R. Lokensgard

Subjects: Get full text

A case of discordant histology and expression of programmed death ligand 1 between primary tumor and brain metastases in adenosquamous carcinoma of the lung by Hironori Takagi, Satoshi Muto, Akio Enta, Mitsuro Fukuhara, Shigeyuki Asano, Yutaka Shio, Hiroyuki Suzuki

Subjects: Get full text

PD-L1 Expression in Medullary Thyroid Carcinoma and Its Association with Clinicopathological Findings by Yasemin KEMAL, Sultan ÇALIŞKAN, Seda GUN, Mehmet KEFELI

Subjects: Get full text

PD-1/PD-L1 and DNA Damage Response in Cancer by Mateusz Kciuk, Damian Kołat, Żaneta Kałuzińska-Kołat, Mateusz Gawrysiak, Rafał Drozda, Ismail Celik, Renata Kontek

Subjects: Get full text

Extracellular Vesicles From Gastric Cancer Cells Induce PD-L1 Expression on Neutrophils to Suppress T-Cell Immunity by Yinghong Shi, Yinghong Shi, Jiahui Zhang, Jiahui Zhang, Zheying Mao, Zheying Mao, Han Jiang, Han Jiang, Wei Liu, Wei Liu, Hui Shi, Hui Shi, Runbi Ji, Runbi Ji, Wenrong Xu, Wenrong Xu, Hui Qian, Hui Qian, Xu Zhang, Xu Zhang

Subjects: Get full text

Case report: Targeting the PD-1 receptor and genetic mutations validated in primary histiocytic sarcoma with hemophagocytic lymphohistiocytosis by Yan Zhao, Yating Deng, Yi Jiang, Wenli Zheng, Yanlin Tan, Zhiwu Yang, Zhihua Wang, Feng Xu, Zhao Cheng, Lingli Yuan, Hongling Peng, Hongling Peng

Subjects: Get full text

HCV Core Protein–ISX Axis Promotes Chronic Liver Disease Progression via Metabolic Remodeling and Immune Suppression by Li‐Ting Wang, Shen‐Nien Wang, Shyh‐Shin Chiou, Jhih‐Peng Tsai, Chee‐Yin Chai, Li‐Wen Tseng, Jin‐Ching Lee, Ming‐Hong Lin, Shau‐Ku Huang, Shih‐Hsien Hsu

Subjects: Get full text

Emerging role of deubiquitination modifications of programmed death-ligand 1 in cancer immunotherapy by Yao Jiang, Yao Jiang, Kai Hong, Yingchao Zhao, Yingchao Zhao, Kai Xu

Subjects: Get full text

Expression of Programmed Death Receptor 1 (PD-1) Gene and Its Ligand (PD-L1) in Patients with Laryngeal Cancer by Andrzej Kowalski, Katarzyna Malinowska, Jurek Olszewski, Hanna Zielińska-Bliźniewska

Subjects: Get full text

Immune checkpoint inhibitors in sarcomas: a systematic review by M. Anastasiou, A. Kyriazoglou, I. Kotsantis, P. Economopoulou, M. Kyrkasiadou, A. Giannopoulou, A. Kosmidou, D. Smerdi, M. Moutafi, N. Gavrielatou, A. Psyrri

Subjects: Get full text

A Clinical Analysis of Anti-Programmed Death-Ligand 1 (PD-L1) Immune Checkpoint Inhibitor Treatments Combined with Chemotherapy in Untreated Extensive-Stage Small-Cell Lung Cancer by Ping-Chih Hsu, Bing-Chen Wu, Chin-Chou Wang, Li-Chung Chiu, Chiung-Hsin Chang, Ping-Chi Liu, Chiao-En Wu, Scott Chih-Hsi Kuo, Jia-Shiuan Ju, Allen Chung-Cheng Huang, Yu-Ching Lin, Cheng-Ta Yang, How-Wen Ko

Subjects: Get full text

Tumor Area Positivity (TAP) score of programmed death-ligand 1 (PD-L1): a novel visual estimation method for combined tumor cell and immune cell scoring by Chunyan Liu, Fang Fang, Ying Kong, Ehab A. ElGabry

Subjects: “…Programmed death-ligand 1 (PD-L1)…”
Get full text

Expression and Clinical Significance of PD-1 and PD-L1 in Pulmonary Carcinoids by Mingbiao LI, Song XU, Haiyang FAN, Hongyi ZHANG, Ying LI, Yongwen LI, Minghui LIU, Hongyu LIU, Jun CHEN

Subjects: Get full text

Prognostic Value of Galectin-9 Relates to Programmed Death-Ligand 1 in Patients With Multiple Myeloma by Byung-Hyun Lee, Yong Park, JI-Hea Kim, Ka-Won Kang, Seung-Jin Lee, Seok Jin Kim, Byung Soo Kim, Byung Soo Kim

Subjects: Get full text

Detection of PD-L1 expression levels in malignant pleural mesothelioma with a targeted MRI nanoprobe in vivo by Zhenghua Zhang, Yang Tian, Wenjun Gao, Yubin Hu, Liangping Luo, Lichang Lei, Shasha Shen, Dan Han

Subjects: Get full text

ICSBP-induced PD-L1 enhances osteosarcoma cell growth by Jee Young Sung, June Hyuk Kim, Hyun Guy Kang, Jong Woong Park, Seog-Yun Park, Byung-Kiu Park, Yong-Nyun Kim

Subjects: Get full text

Case report: Inflammatory sternoclavicular joint arthritis induced by an immune checkpoint inhibitor with remarkable responsiveness to infliximab by Shion Kachi, Shuji Sumitomo, Hideki Oka, Akito Hata, Koichiro Ohmura

Subjects: Get full text

First‐line immune checkpoint therapy in metastatic squamous cell lung cancer harboring both EGFR mutation and high expression of PD‐L1: A case report by Kosuke Hamai, Hiroki Tanahashi, Sayaka Ueno, Hanae Konishi, Mirai Matsumura, Akio Nomura, Kanako Nakamoto, Shoko Isoyama, Takuya Tanimoto, Hiroyasu Shoda, Nobuhisa Ishikawa

Subjects: Get full text

Dynamic change of PD-L1 expression on circulating tumor cells in advanced solid tumor patients undergoing PD-1 blockade therapy by Chunyan Yue, Yubo Jiang, Ping Li, Yuehua Wang, Jian Xue, Nannan Li, Da Li, Ruina Wang, Yongjun Dang, Zhiyuan Hu, Yanlian Yang, Jianming Xu

Subjects: Get full text